EVMN
EvommuneยทNYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About EVMN
Evommune, Inc.
A U.S.biotech company focused on diseases such as urticaria and atopic dermatitis,with tissue genetics as the core of its R&D,holding multiple clinical-stage therapies
1841 Page Mill Road
Suite 100
Palo Alto
CA 94304
--
Evommune, Inc., a Delaware corporation incorporated in April 2020, is headquartered in Palo Alto, California. The company is a clinical-stage biotechnology company focused on the development of innovative treatments for the main pathogenic factors of chronic inflammatory diseases. Its initial clinical development projects focus on chronic spontaneous urticaria, atopic dermatitis and ulcerative colitis.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
